DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months
HIT Consultant
MAY 9, 2023
For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of telemedicine flexibilities regarding the prescription of controlled medications established during the COVID-19 PHE will be extended for one year – through November 11, 2024.
Let's personalize your content